Hyperion DeFi Unwinds Major Digital Asset Agreements, Repositions $28.7M in HYPE Tokens
HYPD sits 44% above its 52-week low of $2.11.
Summary
Hyperion DeFi is unwinding two major digital asset agreements, recovering $28.7 million in HYPE tokens, and plans to reposition these assets into new strategies following the termination of the USDH stablecoin.
Key Events · Corporate Governance and Compliance · HYPD
-
Native Markets Agreement Terminated
Native Markets, Inc. terminated its Temporary Use Agreement with Hyperion DeFi, effective June 18, 2026. The company has recovered 300,000 HYPE tokens and received all owed fees.
-
HAUS Agreement Wind-Down with Felix
Hyperion DeFi agreed with Felix Foundation to wind down their HAUS Agreement. The company anticipates unstaking 500,000 HYPE tokens by June 22, 2026, and expects to receive all remaining payments by June 29, 2026.
-
Significant Asset Repositioning
The company plans to reposition approximately 800,000 HYPE tokens, valued at $28.7 million as of March 31, 2026, into new strategies expected to be more profitable.
Analysis · HYPD · Life Sciences
This filing details Hyperion DeFi's response to the termination of the USDH stablecoin, a risk previously highlighted in recent filings. The company is unwinding two significant digital asset agreements, recovering approximately $28.7 million in HYPE tokens (as of March 31, 2026) and plans to redeploy these assets into new, potentially more profitable strategies. This represents a substantial strategic pivot for a significant portion of the company's assets.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 35.7% of the 1694 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.10%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYPD was trading at $3.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $45.3M. The 52-week trading range was $2.11 to $17.18. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.